<DOC>
	<DOCNO>NCT01269372</DOCNO>
	<brief_summary>This pilot , multi center study establish effectiveness Given PillCam® Platform PillCam® Colon 2 Capsule demonstrate identification subject polyps , compare standard colonoscopy . This study also use evaluate administrative feasibility data management study design .</brief_summary>
	<brief_title>Evaluation Capsule Endoscopy With PillCam® Colon 2 Visualization Colon</brief_title>
	<detailed_description />
	<criteria>1 . Subject 50 75 year age , appropriate candidate polyp screening . 2 . Subject received explanation nature study agree provide write informed consent . 1 . Subject history colorectal cancer 2 . Subjects history positive colon assessment ( include CT , colonoscopy , sigmoidoscopy etc . ) , 3 . Subject history negative colon assessment ( include CT , colonoscopy , sigmoidoscopy etc . ) &lt; 5 year . 4 . Subject first degree relative diagnose colorectal cancer age 60 year old 2 ( ) first degree relative diagnose colorectal cancer age . 5 . Subject suspect diagnosed familial adenomatous polyposis . 6 . Subject suspect diagnosed hereditary nonpolyposis colon cancer . 7 . Subject suspect diagnosed inflammatory bowel disease , chronic ulcerative colitis Crohn 's disease . 8 . Subject suspect diagnosed hematochezia , melena , Fe deficiency anemia rectal bleeding. , include positive FOBT test variety 9 . Subject suspect diagnosed bowel obstruction . 10 . Subject dysphagia swallow disorder . 11 . Subject congestive heart failure . 12 . Subject Diabetes . 13 . Subject prior abdominal surgery gastrointestinal tract last 6 month uncomplicated procedure would unlikely lead bowel obstruction base clinical judgment investigator . 14 . Subject cardiac pacemaker implant electro medical device . 15 . Subject allergy know contraindication medication use study . 16 . Subject expect undergo MRI examination within 7 day ingestion capsule . 17 . Subject condition believe increase risk capsule retention intestinal tumor , radiation enteritis , incomplete colonoscopy due obstruction NSAID enteropathy . 18 . Subject stricture , fistula and/or chronic constipation . 19 . Subject history clinical evidence renal disease and/or previous clinically significant laboratory abnormality renal function parameter . 20 . Subject know gastrointestinal motility disorder . 21 . Subject know delayed gastric empty . 22 . Subject condition , preclude compliance study and/or device instruction . 23 . Women either pregnant nursing time screening , childbearing potential practice medically acceptable method contraception . 24 . Subject suffers life threaten condition . 25 . Subject currently participate another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>polyp</keyword>
	<keyword>capsule endoscopy</keyword>
	<keyword>colonoscopy</keyword>
</DOC>